Related Experiment Video
Updated: Jun 10, 2026

Elucidating β-1,3-Glucanase and Peroxidase Physicochemical Properties of Wheat Cell Wall Defense Mechanism Against Diuraphis noxia Infestation
Published on: July 26, 2024
Beta-glucosidase isolated from soybean okara shows specificity toward glucosyl isoflavones
Tai-Ying Chiou1, Yi-Hsuan Lin, Nan-Wei Su
1Department of Agricultural Chemistry, National Taiwan University, Taipei 10617, Taiwan.
Abstract:
A novel beta-glucosidase was isolated from soybean okara in this study. Along with the beta-glucosidase, a considerable basic 7S globulin of soybean was obtained in the initial extraction products. The protein samples pretreated with 130 mM dithiothreitol before the step of CM-Sepharose chromatography could greatly enhance the separation of the targeted beta-glucosidase from the impurities. The purified beta-glucosidase was found to be a monomer estimated to be 75 kDa by SDS-PAGE. The optimal temperature and pH for this beta-glucosidase were 45 degrees C and 4.5, respectively. The activity of this purified beta-glucosidase was completely inhibited by 1 mM Hg(2+) or 10 mM Al(3+) ion, and glucose and mannose also affected the activity. This beta-glucosidase possessed strict specificity toward glucosyl isoflavones but not malonylglucosidic conjugates of isoflavones of soybean. The N-terminal amino acid sequence of the beta-glucosidase was EYLKYKDPKA-, which highly matched that of glycosidases in maize (Zea mays) and wheat (Triticum asetivum).
More Related Videos
13:35Structural Biology and Analytical Chemistry Approaches for Characterizing C-Glycoside Metabolic Enzymes in Human Gut Microbiota
Published on: May 23, 2025
10:09A Straightforward Method for Glucosinolate Extraction and Analysis with High-pressure Liquid Chromatography (HPLC)
Published on: March 15, 2017
Related Concept Videos
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are typically...
Oligosaccharide Assembly
Multiple sugar molecules that may or may...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...